Imprimis NJOF, LLC recalls Dexamethasone Moxifloxacin
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Presence of particulate matter - Glass like particles.
- Products
-
- Dexamethasone Moxifloxacin
- Company
- Imprimis NJOF, LLC
- Where it was sold
-
U.S Nationwide
Nationwide
- Units affected
- 778 boxes of 15,540 pre-filled syringes
- About this recall
- Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1